RMD or PODD: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with ResMed (RMD) and Insulet (PODD). But which of these two companies is the best option for those looking for undervalued stocks?
Here is Why Growth Investors Should Buy ResMed (RMD) Now
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why ResMed (RMD) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RMD vs. LMAT: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either ResMed (RMD) or LeMaitre Vascular (LMAT). But which of these two companies is the best option for those looking for undervalued stocks?
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why You Should Add RMD Stock to Your Portfolio Now
Robust Mask and Device sales bode well for ResMed. Meanwhile, the increasing debt burden adds to the worry.
Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
ResMed (RMD) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why ResMed (RMD) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ResMed CEO On Earnings, Sleep Apnea
ResMed (RMD) CEO Mick Farrell joins Morning Trade Live to discuss the company's latest earnings beat. ResMed primarily focuses on sleep apnea and COPD.
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run?
ResMed (RMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
